Literature DB >> 22090007

The role of interleukin-23/interleukin-17 axis in the development of systemic lupus erythematosus among patients with tuberculosis: comment on: Lin YC, Liang SJ, Liu YH et al.: tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. (Rheumatol Int. 2011 Mar 18. [Epub ahead of print]).

Se Jin Park, Ji Hong Kim, Tae Sun Ha, Jae Il Shin.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22090007     DOI： 10.1007/s00296-011-2226-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  7 in total

1.  The role of interleukin-23/interleukin-17 axis in the development of systemic lupus erythematosus among patients with tuberculosis: comment on: Lin YC, Liang SJ, Liu YH et al.: tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. (Rheumatol Int. 2011 Mar 18. [Epub ahead of print]).

Authors:  Se Jin Park; Ji Hong Kim; Tae Sun Ha; Jae Il Shin
Journal:  Rheumatol Int       Date:  2011-11-17       Impact factor: 2.631

Review 2.  IL-17 and Th17 cells in tuberculosis.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

3.  Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice.

Authors:  Vasileios C Kyttaris; Zheng Zhang; Vijay K Kuchroo; Mohamed Oukka; George C Tsokos
Journal:  J Immunol       Date:  2010-03-22       Impact factor: 5.422

4.  Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.

Authors:  Kamini Shah; Won-Woo Lee; Seung-Hyun Lee; Sang Hyun Kim; Seong Wook Kang; Joe Craft; Insoo Kang
Journal:  Arthritis Res Ther       Date:  2010-03-24       Impact factor: 5.156

Review 5.  IL-23 and IL-17 in tuberculosis.

Authors:  Shabaana A Khader; Andrea M Cooper
Journal:  Cytokine       Date:  2008-01-22       Impact factor: 3.861

6.  Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Authors:  Agnès Doreau; Alexandre Belot; Jérémy Bastid; Benjamin Riche; Marie-Claude Trescol-Biemont; Bruno Ranchin; Nicole Fabien; Pierre Cochat; Claire Pouteil-Noble; Pierre Trolliet; Isabelle Durieu; Jacques Tebib; Berhouz Kassai; Stéphane Ansieau; Alain Puisieux; Jean-François Eliaou; Nathalie Bonnefoy-Bérard
Journal:  Nat Immunol       Date:  2009-05-31       Impact factor: 25.606

7.  Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

Authors:  Chun Kwok Wong; Lydia Choi Wan Lit; Lai Shan Tam; Edmund Kwok Ming Li; Purple Tsz Yan Wong; Christopher Wai Kei Lam
Journal:  Clin Immunol       Date:  2008-03-25       Impact factor: 3.969
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.